QCG
IRMD icon

Quadrant Capital Group’s iRadimed IRMD Stock Holding History

Quadrant Capital Group’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-57
Closed -$3K – 2590
2021
Q4 		$3K Buy
+57
New +$2.3K ﹤0.01% 2036
2021
Q2 		– Sell
-12
Closed – – 2476
2021
Q1 		$0 Buy
+12
New +$287 ﹤0.01% 2420
2017
Q2 		– Sell
-526
Closed -$4K – 1948
2017
Q1 		$4K Hold
526
– – ﹤0.01% 1411
2016
Q4 		$5K Buy
+526
New +$5.66K ﹤0.01% 1242

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCG
Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

Quadrant Capital Group's IRMD Position: Q1 2022 in Review

Quadrant Capital Group sold out of iRadimed (IRMD) in Q1 2022, closing a stake of 57 shares — an estimated $3K sold.

Quadrant Capital Group first reported a position in IRMD in Q4 2016 and held it in 4 quarters. The position peaked at $5K in Q4 2016. 103 funds tracked by Wall St. Rank hold IRMD as of Q1 2022.

  • Quadrant Capital Group reported no remaining iRadimed position as of Q1 2022 after selling out during the quarter.
  • Quadrant Capital Group sold 57 iRadimed shares in Q1 2022, an estimated $3K.
  • Quadrant Capital Group first reported a position in iRadimed in Q4 2016 and held it in 4 quarters.
  • Quadrant Capital Group's iRadimed position peaked at $5K in Q4 2016.
  • 103 funds tracked by Wall St. Rank held iRadimed as of Q1 2022.

Based on Quadrant Capital Group's 13F filing for Q1 2022, filed 6 May 2022.